Verrica Pharmaceuticals Inc. SEC filings VRCA

Verrica Pharmaceuticals Inc. has 534 filings in SEC EDGAR's recent list, going back to Dec 17, 2015. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.

Verrica Pharmaceuticals Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 9, 2026 Jun 5, 2026
S-8 Employee stock plan registration May 12, 2026 —
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 12, 2026 May 12, 2026
ARS Annual report to shareholders Apr 20, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 20, 2026 —
DEF 14A Proxy statement Apr 20, 2026 Jun 5, 2026
10-K Annual report Mar 11, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 11, 2026 Mar 11, 2026
8-K Current report
Officer or director change
Dec 30, 2025 Dec 23, 2025
EFFECT Filing Dec 23, 2025 —
424B3 Prospectus Dec 23, 2025 —
CORRESP Letter to the SEC Dec 19, 2025 —
S-3 Shelf registration Dec 15, 2025 —
D Filing Dec 10, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Nov 24, 2025 Nov 23, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 14, 2025 Nov 14, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations, Other events
Aug 12, 2025 Aug 8, 2025
8-K Current report
Listing notice
Jul 30, 2025 Jul 24, 2025
8-K Current report
Change to shareholder rights
Jul 23, 2025 Jul 22, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Jul 1, 2025 Jun 27, 2025
8-K Current report
Material agreement
Jun 12, 2025 Jun 10, 2025
8-K Current report
Shareholder vote results
Jun 5, 2025 Jun 5, 2025
S-8 Employee stock plan registration May 13, 2025 —
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 13, 2025 May 13, 2025
DEFR14A Filing Apr 30, 2025 —
8-K Current report
Officer or director change
Apr 25, 2025 Apr 22, 2025
ARS Annual report to shareholders Apr 22, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 22, 2025 —
DEF 14A Proxy statement Apr 22, 2025 Jun 5, 2025
PRE 14A Preliminary proxy statement Apr 11, 2025 Jun 5, 2025
8-K Current report
Officer or director change
Apr 2, 2025 Mar 31, 2025
EFFECT Filing Mar 25, 2025 —
CORRESP Letter to the SEC Mar 21, 2025 —
UPLOAD Letter from the SEC Mar 17, 2025 —
S-3 Shelf registration Mar 11, 2025 —
10-K Annual report Mar 11, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 11, 2025 Mar 11, 2025
8-K Current report
Material agreement
Feb 21, 2025 Feb 18, 2025
8-K Current report
Listing notice
Jan 30, 2025 Jan 24, 2025
S-8 Employee stock plan registration Dec 9, 2024 —
8-K Current report
Officer or director change
Dec 9, 2024 Dec 4, 2024
8-K Current report
Material agreement, Other events
Nov 21, 2024 Nov 20, 2024
424B5 Prospectus supplement Nov 21, 2024 —
8-K Current report
Other events
Nov 20, 2024 Nov 20, 2024
424B5 Prospectus supplement Nov 20, 2024 —
S-8 Employee stock plan registration Nov 6, 2024 —
10-Q Quarterly report Nov 5, 2024 Sep 30, 2024
8-K Current report
Results of operations, Officer or director change
Nov 4, 2024 Nov 1, 2024
8-K Current report
Listing notice, Officer or director change
Oct 8, 2024 Oct 2, 2024
8-K Current report
Exit or restructuring costs
Oct 1, 2024 Oct 1, 2024
8-K Current report
Officer or director change
Sep 27, 2024 Sep 23, 2024
8-K Current report
Officer or director change
Sep 6, 2024 Aug 30, 2024
8-K Current report
Officer or director change
Aug 27, 2024 Aug 21, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 14, 2024 Aug 14, 2024
8-K Current report
Material agreement
Aug 5, 2024 Aug 2, 2024
8-K Current report
Material agreement
Jun 28, 2024 Jun 26, 2024
8-K Current report
Shareholder vote results
Jun 10, 2024 Jun 6, 2024
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
May 15, 2024 May 14, 2024
S-8 Employee stock plan registration May 13, 2024 —
10-Q Quarterly report May 13, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 13, 2024 May 13, 2024
ARS Annual report to shareholders Apr 19, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 19, 2024 —
DEF 14A Proxy statement Apr 19, 2024 Jun 6, 2024
10-K Annual report Feb 29, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 29, 2024 Feb 29, 2024
8-K Current report
Regulation FD disclosure
Jan 8, 2024 Jan 8, 2024
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Regulation FD disclosure
Jul 27, 2023 Jul 27, 2023
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
Jul 26, 2023 Jul 26, 2023
8-K Current report
Regulation FD disclosure, Other events
Jul 24, 2023 Jul 21, 2023
8-K Current report
Shareholder vote results
Jun 8, 2023 Jun 8, 2023
10-Q Quarterly report May 9, 2023 Mar 31, 2023
S-8 Employee stock plan registration May 9, 2023 —
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
DEFA14A Additional proxy material Apr 21, 2023 —
DEF 14A Proxy statement Apr 21, 2023 Jun 8, 2023
ARS Annual report to shareholders Apr 21, 2023 Dec 31, 2022
10-K Annual report Mar 6, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 6, 2023 Mar 6, 2023
424B5 Prospectus supplement Feb 22, 2023 —
8-K Current report
Material agreement, Other events
Feb 21, 2023 Feb 21, 2023
FWP Free writing prospectus Feb 21, 2023 —
8-K Current report
Results of operations, Other events
Feb 21, 2023 Feb 21, 2023
8-K Current report
Regulation FD disclosure
Feb 2, 2023 Feb 2, 2023
8-K Current report
Other events
Jan 24, 2023 Jan 24, 2023
EFFECT Filing Dec 19, 2022 —
424B5 Prospectus supplement Dec 19, 2022 —
CORRESP Letter to the SEC Dec 15, 2022 —
UPLOAD Letter from the SEC Nov 29, 2022 —
CORRESP Letter to the SEC Nov 18, 2022 —
UPLOAD Letter from the SEC Nov 15, 2022 —
UPLOAD Letter from the SEC Nov 8, 2022 —
S-3 Shelf registration Nov 7, 2022 —
10-Q Quarterly report Nov 7, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 7, 2022 Nov 7, 2022
8-K Current report
Regulation FD disclosure
Sep 14, 2022 Sep 14, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 11, 2022 Aug 11, 2022
8-K Current report
Other events
Jul 13, 2022 Jul 13, 2022
8-K Current report
Material agreement, Other events
Jul 1, 2022 Jun 29, 2022
424B5 Prospectus supplement Jul 1, 2022 —
424B5 Prospectus supplement Jun 29, 2022 —
8-K Current report
Shareholder vote results
Jun 14, 2022 Jun 9, 2022
8-K Current report
Exit or restructuring costs
Jun 3, 2022 May 31, 2022
8-K Current report
Other events
May 25, 2022 May 24, 2022
S-8 Employee stock plan registration May 9, 2022 —
10-Q Quarterly report May 9, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 9, 2022 May 9, 2022
DEFA14A Additional proxy material Apr 22, 2022 —
DEF 14A Proxy statement Apr 22, 2022 Jun 9, 2022
8-K Current report
Regulation FD disclosure
Apr 7, 2022 Apr 7, 2022
10-K Annual report Mar 2, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 2, 2022 Mar 2, 2022
8-K Current report
Other events
Dec 15, 2021 Dec 15, 2021
8-K Current report
Regulation FD disclosure, Other events
Nov 29, 2021 Nov 29, 2021
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 12, 2021 Nov 12, 2021
8-K Current report
Regulation FD disclosure
Sep 29, 2021 Sep 29, 2021
8-K Current report
Other events
Sep 20, 2021 Sep 20, 2021
10-Q Quarterly report Aug 10, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 10, 2021 Aug 10, 2021
8-K Current report
Officer or director change
Jul 9, 2021 Jul 6, 2021
8-K Current report
Shareholder vote results
Jun 10, 2021 Jun 10, 2021
8-K Current report
Other events
May 28, 2021 May 28, 2021
S-8 Employee stock plan registration May 7, 2021 —
10-Q Quarterly report May 7, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 7, 2021 May 7, 2021
DEFA14A Additional proxy material Apr 23, 2021 —
DEF 14A Proxy statement Apr 23, 2021 Jun 10, 2021
SEC STAFF LETTER Filing Apr 19, 2021 —
8-K Current report
Material agreement, Other events
Mar 23, 2021 Mar 22, 2021
424B5 Prospectus supplement Mar 23, 2021 —
424B5 Prospectus supplement Mar 22, 2021 —
SEC STAFF LETTER Filing Mar 22, 2021 —
10-K Annual report Mar 17, 2021 Dec 31, 2020
8-K Current report
Material agreement
Mar 17, 2021 Mar 17, 2021
8-K Current report
Results of operations
Mar 4, 2021 Mar 4, 2021
8-K Current report
Other events
Feb 17, 2021 Feb 17, 2021
8-K Current report
Regulation FD disclosure
Jan 6, 2021 Jan 6, 2021
8-K Current report
Other events
Dec 23, 2020 Dec 23, 2020
8-K Current report
Regulation FD disclosure
Nov 10, 2020 Nov 10, 2020
10-Q Quarterly report Nov 9, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 9, 2020 Nov 9, 2020
8-K Current report
Regulation FD disclosure
Sep 8, 2020 Sep 8, 2020
8-K Current report
Material agreement
Aug 11, 2020 Aug 7, 2020
10-Q Quarterly report Aug 5, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 5, 2020 Aug 5, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 23, 2020 Jul 22, 2020
8-K Current report
Results of operations, Other events
Jul 14, 2020 Jul 14, 2020
8-K Current report
Other events
Jun 29, 2020 Jun 29, 2020
8-K Current report
Shareholder vote results
Jun 11, 2020 Jun 11, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 10, 2020 Jun 9, 2020
10-Q Quarterly report May 7, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
DEFA14A Additional proxy material Apr 24, 2020 —
DEF 14A Proxy statement Apr 24, 2020 Jun 11, 2020
8-K Current report
Regulation FD disclosure, Other events
Apr 17, 2020 Apr 17, 2020
EFFECT Filing Mar 25, 2020 —
CORRESP Letter to the SEC Mar 23, 2020 —
UPLOAD Letter from the SEC Mar 23, 2020 —
S-8 Employee stock plan registration Mar 13, 2020 —
S-3 Shelf registration Mar 13, 2020 —
10-K Annual report Mar 13, 2020 Dec 31, 2019
8-K Current report
Material agreement, Results of operations, New debt, Regulation FD disclosure
Mar 13, 2020 Mar 10, 2020
8-K Current report
Regulation FD disclosure
Mar 2, 2020 Mar 2, 2020
8-K Current report
Officer or director change
Jan 16, 2020 Jan 10, 2020
8-K Current report
Listing notice
Nov 20, 2019 Nov 20, 2019
10-Q Quarterly report Nov 6, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 6, 2019 Nov 6, 2019
8-K Current report
Officer or director change
Oct 24, 2019 Oct 18, 2019
8-K Current report
Regulation FD disclosure
Oct 18, 2019 Oct 18, 2019
8-K Current report
Officer or director change
Oct 10, 2019 Oct 4, 2019
8-K Current report
Officer or director change
Oct 4, 2019 Sep 30, 2019
10-Q Quarterly report Aug 7, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 7, 2019 Aug 7, 2019
8-K Current report
Material agreement
Jul 1, 2019 Jul 1, 2019
8-K Current report
Regulation FD disclosure
Jun 27, 2019 Jun 26, 2019
8-K Current report
Officer or director change
Jun 14, 2019 Jun 13, 2019
8-K Current report
Shareholder vote results
Jun 12, 2019 Jun 12, 2019
S-8 Employee stock plan registration May 7, 2019 —
10-Q Quarterly report May 7, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 7, 2019 May 7, 2019
DEFA14A Additional proxy material Apr 25, 2019 —
DEF 14A Proxy statement Apr 25, 2019 Jun 12, 2019
8-K Current report
Officer or director change
Apr 17, 2019 Apr 12, 2019
10-K Annual report Mar 7, 2019 Dec 31, 2018
8-K Current report
Results of operations, Change to shareholder rights, Other events
Mar 7, 2019 Mar 7, 2019
8-K Current report
Regulation FD disclosure
Jan 3, 2019 Jan 3, 2019
CT ORDER Filing Dec 17, 2018 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
VRCA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
West Chester, PA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1660334

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.